Healthtech Series A Investors & VC Firms
2310 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
XAnge
ParisPre-Seed–Series B$1.1M – $10.8M
22 people
Alexandria
PasadenaSeed–Series B
41 people
Forbion
NaardenPre-Seed–Late Stage
25 people
HealthCap
StockholmSeed–Growth
33 people
Ascension Ventures
Saint LouisSeed–Late Stage$10M – $20M
18 people
Northpond Ventures
BethesdaSeed–Series A$100K – $5M
37 people
High Alpha
IndianapolisSeed–Series B
23 people
UntroD Capital
TokyoSeed–Growth
38 people
Anicut Capital
New DelhiPre-Seed–Late Stage
39 people
Horizons Ventures
Hong KongSeed–Growth$500K – $10M
24 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
15 people
Giant Ventures Global Llp
LondonPre-Seed–Growth$10M – $20M
32 people
Serena
ParisPre-Seed–Series B$100K – $15M
32 people
Eight Capital
NorwalkSeed–Series B
4 people
Abingworth
LondonSeed–Series C$15M – $30M
43 people
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
43 people
Daphni
ParisSeed–Series B$540K – $6.5M
32 people
Sofina
BrusselsSeed–Late Stage$100M – $300M
57 people
Inspired Capital
New YorkPre-Seed–Growth$500K – $20M
20 people
Golden Gate Ventures
SingaporePre-Seed–Growth$1M – $5M
24 people
OUP (Osage University Partners)
Bala CynwydPre-Seed–Late Stage$1M – $20M
21 people
Metaplanet
TallinnSeed–Series B$500K – $10M
4 people
AppWorks Ventures
TaipeiPre-Seed–Series C$200K – $15M
26 people
Greenoaks
San FranciscoSeed–Late Stage$1M – $50M
17 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Healthtech Investors & VC Firms (4191)Series A Investors & VC Firms in United States (3839)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Healthtech Investors & VC Firms in United States (2437)Series A Investors & VC Firms in Europe (2384)
Data sourced from public filings and firms' own websites — see our methodology.













































































































